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The product of the Msx1 gene is a potent inhibitor of muscle differentiation. Msx1 is expressed in muscle precursor cells of the limb bud that
also express Pax3. It is thought that Msx1 may facilitate distal migration by delaying myogenesis in these cells. Despite the role played by Msx1 in
inhibiting muscle differentiation, nothing is known of the mechanisms that support the expression of the Msx1 gene within limb bud muscle
precursor cells. In the present study we have used a combination of comparative genomics, mouse transgenic analysis, in situ hybridisation and
immunohistochemistry to identify a highly conserved and tissue-specific regulatory sub-domain within the previously characterised Msx1 gene
proximal enhancer element that supports the expression of the Msx1 gene in Pax3-expressing mouse limb pre-muscle masses. Furthermore, using
a combination of in situ hybridisation, in vivo ChIP assay and transgenic explant culture analysis we provide evidence that Msx1 expression in
limb bud muscle precursor cells is dependent on the canonical Wnt/TCF signalling pathway that is important in muscle shape formation. The
results of these studies provide evidence of a mechanistic link between the Wnt/TCF and the Msx1/Pax3/MyoD pathways within limb bud muscle
precursor cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: Transcriptional regulation; Comparative genomics; Transgenic mouse; Limb bud muscle precursor cells; Msx1; Pax3; Tcf4; Wnt signallingIntroduction
The Msx genes encode a class of homeodomain containing
transcription factors that are expressed in a variety of different
developing organ systems such as the developing neural tube
(Ramos and Robert, 2005), the developing craniofacial region
and dentition (Chen et al., 1996; Ferguson et al., 1992;
MacKenzie et al., 1991a, 1992) and limb buds (Davidson et
al., 1991) where they are essential for normal development
(Houzelstein et al., 1997; Ishii et al., 2005; Lallemand et al.,
2005). It has been shown that the best characterised member
of this family, Msx1, exerts its effects on development by
acting as a general repressor of terminal differentiation⁎ Corresponding author.
E-mail address: mbi167@abdn.ac.uk (A. MacKenzie).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.07.022(Houzelstein et al., 1999) within cell types that include
developing bone (Berdal et al., 2002; Orestes-Cardoso et al.,
2002) and muscle (Houzelstein et al., 1999; Odelberg et al.,
2000; Thompson-Jaeger and Raghow, 2000; Woloshin et al.,
1995). A number of different studies have shown that Msx1
down-regulates the expression of the muscle differentiation
factor MyoD (Woloshin et al., 1995), prevents differentiation
of murine myoblast cells (Thompson-Jaeger and Raghow,
2000) and, uniquely, can reverse the terminal differentiation
of murine myotubes (Odelberg et al., 2000). Moreover, Msx1
is expressed within muscle precursor cells of the limb buds
(Houzelstein et al., 1999) where it has been shown that Msx1
protein antagonises myogenic activity of the Pax3 protein by
direct protein–protein interaction (Bendall et al., 1999).
Together, these studies suggest a role for Msx1 in retarding
myogenesis in the limb bud. It has been hypothesised that
specific prevention of myogenic differentiation within limb
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the distal migration of these cells from their somitic
myotome-derived origins (Bendall et al., 1999; Houzelstein
et al., 1999).
Although Msx1 is a potent inhibitor of muscle differentia-
tion and is expressed in limb bud precursor cells nothing is
known about the regulatory mechanisms that control the
expression of Msx1 in these cells. In an attempt to understand
the processes that co-ordinate the complex temporal and
spatial expression of Msx1 we previously carried out extensive
deletion analyses of 16 kb of DNA flanking the Msx1 gene
(MacKenzie et al., 1997). This analysis succeeded in the
identification and isolation of two enhancers that we called the
distal enhancer (DE, 4 kb 5′ of mouse Msx1 gene
transcriptional start (+1)) and the proximal enhancer (PE,
2.2 kb 5′ of mouse Msx1+1). The DE element was able to
drive the expression of a LacZ marker gene in the developing
nasal processes and the first and second pharyngeal arches.
The PE element supported gene expression in the third
pharyngeal arch, in the dorsal neural tube, within trunk
somitic dermomyotome and extensively within limb bud
mesenchyme (MacKenzie et al., 1997). Parallel studies of
more proximal enhancers by other groups suggested the
presence of a third enhancer directly adjacent to the Msx1
gene transcriptional start site that appeared to be responsible
for supporting expression in the developing tooth mesench-
yme (Takahashi et al., 1997). However, none of these studies
succeeded in identifying the specific sequences that were able
to support expression in Msx1-expressing cells of the limb
muscle precursor cells where Msx1 has been shown to be
expressed together with Pax3 (Bendall et al., 1999; Houzel-
stein et al., 1999).
In the present study we have used comparative genomics and
transgenic analysis to identify a regulatory sub-domain of PE
that supports expression of marker genes in Msx1-expressing
limb muscle precursor cells that also express the myogenic
marker gene Pax3. Furthermore, we present evidence that the
tissue-specific activity of this regulatory sub-domain of the PE
element is reliant on binding of the TCF4 transcription factor
and can be manipulated using agonists and antagonists of the
Wnt signalling pathway. These studies provide evidence of a
mechanistic link between the Wnt/TCF signalling system,
known to influence limb muscle patterning (Anakwe et al.,
2003; Cossu and Borello, 1999; Kardon et al., 2003) and the
Pax3/MyoD system, that is known to modulate the differentia-




Conserved potential transcription factor binding sites within the PE
element were identified using the ECR browser (http://www.ecrbrowser.
dcode.org) with linked rVISTA program (Loots and Ovcharenko, 2004,
2005). Verification of predicted transcription factor binding matrices was
carried out using TRANSFAC professional (BIOBASE Biological Databases)
and integrated MATCH software (Matys et al., 2006). Analysis of theTRANSFAC matrix database also allowed the identification of core nucleo-
tides within the TCF4 recognition matrix that were then manipulated by site
directed mutagenesis.
Plasmid construction
pPEDE (see Table 1)
We have previously shown that the tissue-specific activities of both PE
and DE are mutually exclusive at embryonic day 10.5 (E10.5) developing
embryo (MacKenzie et al., 1997). We exploited these properties of PE and
DE in the production of a unique reporter construct called pPEDE. pPEDE
was designed to facilitate the analysis of either the PE or DE enhancers by
site directed mutagenesis using transgenic embryos. The production of this
double enhancer construct (pPEDE) ensured that, in the eventuality of an
induced mutagenesis event completely inactivating either the PE or DE
elements, the other intact enhancer could act as a rapid reporter of transgenic
status and β-gal staining efficiency in transient transgenic embryos. To
produce pPEDE the DE component was generated by PCR using mouse
genomic DNA as template. The oligonucleotides used to amplify the DE
sequence were as follows: KpnI 3′, GCT GGG TAC CCT TGT GTC TTT
AAA TTC G, SalI 5′, ACT TGG GTC GAC GCC CCT GGA GCC TTA
GGG. This PCR was undertaken over 30 cycles with an annealing
temperature of 60 °C. Once amplified the PCR product was digested with
SalI and KpnI. This product was then ligated into the SalI and KpnI sites of
the plasmid pASβg (MacKenzie et al., 1997) that contains the PE element
linked to the human β-globin promoter driving the LacZ gene, to form
pPEDE. Prior to microinjection into 1-cell mouse embryos pPEDE was
linearised by digestion with SacII to release the transgene from the vector
sequence.
pΔAP2 (see Table 1)
pPEDE was digested with ApaI and the cut ends were blunt-ended using T4
DNA polymerase (T4 pol, Roche). Following inactivation of the T4 pol this
plasmid was digested with SalI to produce a linearised 8.2 kb plasmid (referred
to as vector fragment).
A second aliquot of pPEDE plasmid DNAwas digested with PstI and ends
were blunt-ended with T4 DNA polymerase. Following inactivation of T4 pol
the Plasmid was digested with SalI and the resulting 209 bp fragment was
ligated to the 8.2 kb derived vector to produce pΔAP2.
pΔTES (see Table 1)
pPEDE was digested with NarI and made blunt ended using T4 pol.
Following T4 pol deactivation a 185 bp fragment was released by SalI digestion
and ligated into the 8.2 kb pPEDE-derived vector.
pΔAPΔTCF (see Table 1)
In order to facilitate the site-directed mutagenesis process the PE element
from pΔAP2 was first subcloned into pGEM-5Z (Promega) using enzymes
NcoI and SalI to form p5ΔAP2. Site-directed mutagenesis using the
QuikChange site-directed mutagenesis kit (Stratagene, see Fig. 2 and Table 1,
changed base pairs are highlighted) was carried out on p5ΔAP2 using the
following primers: dAPdTCF.for; CGG CCG GAT CATATG CTT GAA GTC
G and dAPdTCF.rev; CGA CTT CAA GCATAT GAT CCG GCC G to disrupt
the potential TCF transcription factor binding site present in the PE element to
produce p5ΔAPΔTCF. The modified PE elementΔAPΔTCF was then released
from this plasmid p5ΔAPΔTCF using ClaI and NheI and re-ligated to
compatible sites within pΔAP2 to produce plasmid pΔAPΔTCF. Plasmid was
linearised using SacII and purified prior to pronuclear microinjection.
pGEM7/MSX1
Using enzymes SacI and XbaI, the fragment containing the entire mouse
Msx1 cDNA was released from plasmid pH7XS. This fragment was ligated
into corresponding sites within pGEM7 (Promega) to produce pGEM7/Msx1.
Transgenic analysis
Construct DNA was microinjected into 1-cell C57/BL6xCBA F1 mouse
embryos at a concentration of 2–4 ng/μl as previously described (Hogan et al.,
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host mothers (Hogan et al., 1995). Transgenic embryos were then either
recovered at E10.5 or allowed to litter to produce transgenic lines.
Detection of LacZ expression
After dissection embryos were washed briefly in standard wash (2 mM
MgCl2 in PBS) and fixed in 4% paraformaldehyde (PFA) at 4 °C for 1 h.
Embryos were washed using detergent wash (2 mM MgCl2, 0.01% sodium
deoxycholate, 0.02% Nonidet P-40 and 0.05% BSA in 0.1 M phosphate buffer)
for 3×20 min at room temperature. LacZ activity was detected using X-gal stain
(0.1% 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal: Melford
Laboratories), 0.085% NaCl2, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6) and
incubated at 37 °C. Alternatively embryos were stained with salmon-gal
(6-Chloro-3-indolyl-β-D-galactopyranoside; Apollo Scientific Ltd). The salmon-
gal protocol was similar to that for X-gal except that different detergent wash
(2 mM MgCl2, 0.02% Nonidet P-40 and 0.2% PFA in 0.1 M phosphate buffer)
and stain solution (3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6 and 0.4% 6-Chloro-3-
indolyl-β-D-galactopyranoside) were used. Embryos were examined at 2 h, 6 h
and following an overnight incubation to check for sufficient LacZ staining.
After staining, embryos were fixed in 4% PFA at 4 °C for 1 h.
Whole mount in situ hybridisation
Plasmids pGEM7/Msx1 and pmTCF4b (supplied courtesy of Gregory
Dressler) were linearised with NsiI and HindIII respectively for production of
antisense probe. Digoxygenin (DIG) labelled antisense probes were transcribed
from both plasmids using components of the T7 RNA polymerase Maxiscript In
Vitro Transcription Kit (Ambion) as described in the manufacturer's instructions
with the following modifications. DIG-labelled antisense RNA probes were
transcribed in the following reaction; 1× transcription buffer, 0.01 M DTT,
2 mM rNTP mix (0.5 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.32 mM UTP and
0.18 mM dig-UTP; (Roche)), 5 μg linearised template plasmid DNA, 40 units
RNAase inhibitor, RNAasin (Roche) and 90 units of the T7 RNA polymerase in
nuclease-free water to a final volume of 50 μl. Whole-mount in situ
hybridisation with fresh embryos or with embryos previously stained for
LacZ expression was carried out as previously described (Lettice et al., 2002).
Radioactive in situ hybridisation
35S labelled RNA probes were hybridised to 5 μm sections of mouse limb
buds exposed to BMP4-soaked beads as previously described (MacKenzie et al.,
1991a,b, 1992).
Vibratome sectioning
To analyse transgene activity at the tissue level, X-Gal stained embryos were
embedded for vibratome sectioning. Embryos were fixed in 4% paraformalde-
hyde (PFA)/PBS from 1 h to overnight at 4 °C and equilibrated through 4% and
20% sucrose/PBS solutions at 4 °C for 3 h. Embryos were then transferred to
BSA/gelatin mix (0.5% gelatin, 1% BSA and 5% sucrose in PBS) overnight.
Prior to embedding embryos were fixed in 25% glutaraldehyde for 1 min and
embedded in BSA/gelatin containing 0.25% glutaraldehyde. 100 μm sections
were taken on a Lancer Vibratome series 1000.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed as previously described (Barrow et al., 2006)
but with the following modifications. E10.5 mouse embryos were dissected into
2 ml of serum-free media (Gibco, D-MEM plus GlutaMAX I supplemented with
1× penicillin–streptomycin solution) and were treated with Trypsin–EDTA
(Gibco) at 37 °C for 30 min. Trypsinised embryos were disaggregated with fire-
polished Pasteur pipettes to give a 1-cell suspension prior to filtration through a
cell strainer (BD biosciences). Prior to ChIP assays cell suspensions were treated
in the presence or absence of BIO, a GSK-3-selective inhibitor (10 μM, Sigma)
or Forskolin (10 μM, Sigma) (Meijer et al., 2003; Seamon et al., 1981) for 2 h at
37 °C. Following treatment chromatin was cross-linked at 37 °C for 10 min withthe addition of formaldehyde solution to the tissue culture media to a final
concentration of 1%. Fixation was stopped by washing cells in 125 mM glycine
in PBS. Following centrifugation at 2000×g for 5 min at 4 °C cells were washed
three times in 1 ml of PBS plus protease inhibitor cocktail (for 10 ml: 1 mM
PMSF and 1 protease inhibitor Tablet (Roche)). Cells were resuspended in 1 ml
SDS lysis buffer (100 mM EDTA, 500 mM Tris, 0.01% sodium dodecyl
sulphate, 1 mM PMSF and 1 protease inhibitor Tablet; Roche) and incubated on
ice for 10 min. The resulting lysate was sonicated on ice for 10 min using a
Misonix Sonicator 3000 with microtip for 4×10 s pulses to shear chromatin with
1 min pause gap in between each pulse. Sheared chromatin samples were pre-
cleared using 100 μl of Protein-G Dynabeads (pre-prepared as per manufac-
turer's instructions but with addition of 1 mg/ml BSA and 1 μg/ml sheared
salmon sperm DNA) per sample and tubes incubated at 4 °C for 2 h with
rotation. Beads were then magnetised and the cleared lysate removed to fresh
tubes. 5 μg of each immunoprecipitating antibody (TCF4 (mouse monoclonals
raised against human protein), mouse-IgG, Upstate) were added to individual
samples and incubated at 4 °C overnight with rotation. Protein/DNA complexes
were recovered by adding 60 μl pre-blocked Protein-G Dynabeads per sample at
4 °C for a further 2 h, with rotation. Beads were magnetised and supernatant
discarded as this contained unbound, non-specific DNA. Bead washes and
reversal of cross-links was carried out as previously described (Barrow et al.,
2006).
To remove RNA from the sample, 10 μg RNAase A (Sigma) was added to
each tube and incubated for 1 h at 37 °C. Proteins were digested with the
addition of 4 mM EDTA (pH 8), 4 μg proteinase K (Roche) and incubated at
42 °C for 2 h. DNA was purified by phenol/chloroform/isoamyl alcohol
extraction; DNA was extracted twice with an equal volume of phenol/
chloroform/isoamyl alcohol (Sigma) and once with chloroform/isoamyl alcohol
(Sigma), using phase-lock gel tubes (Eppendorf) with centrifugation at
13,000 rpm for 5 min at each step. The upper phase was concentrated and
washed using Microcon YM-30 centrifugal filter units (Millipore) with 50 μl
molecular biology grade water (Sigma) and eluted into 50 μl as per
manufacturer's instructions. Bound DNA was detected using 30 cycles of
standard PCR (GoTaq, Promega) using primers specific for the endogenous
mouse PE element; mChPE1.for; GAT CGG AGA ATC CAA GTA GCT AC
and mChPE1.rev; GAC AGT GGA GTT TGA GAC CTA CTC with an
annealing temperature of 60.5 °C followed by densitometry studies of product
quantities following standard gel electrophoresis using ImageJ (http://www.rsb.
info.nih.gov/ij/). During subsequent experiments quantification of bound DNA
was performed using SYBR Green (Lightcycler 480, Roche) quantitative PCR
using the same mChPE1 primers shown previously.
Wnt, FGF and BMP agonist/antagonist studies of pΔAP2 transgenic
limb bud explants
50–200 μm AG-1X2-formate beads, were soaked in a 5 μM solution of Wnt
agonist (2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)
pyrimidine; Calbiochem) dissolved in di-methyl sulphoxide (DMSO) for 2 h at
room temperature in the dark. AG-1X2-formate beads were also soaked in a
100 mM solution of the FGF antagonist SU5402 (3-[3-(2-Carboxyethyl)-4-
methylpyrrol-2-methylidenyl]-2-indolinone; Calbiochem) dissolved in DMSO.
50–200 μm Affigel Blue beads were soaked for 2 h in a 2 μg/ml solution of
recombinant mouse Dickkopf-related protein 1 (DKK-1; R&D Systems) in PBS.
Affigel Blue beads were soaked for 1 h in solutions (100 μg/ml in 4 mM HCl/
0.1% BSA in PBS) of bone morphogenic protein 4 (R&D Systems). Affigel
Blue beads were also soaked for 1 h in a 0.5 μg/ml solution of the BMP
antagonist noggin (R&D Systems) in PBS/0.1% BSA.
Beads were then applied to E10.5 pΔAP2 transgenic limb bud explants
cultured on Millicell Culture Plate Inserts (Millipore) with D-MEM medium
supplemented with 2 mM GlutaMAX (Invitrogen), 100 U/ml penicillin,
100 μg/ml streptomycin (Invitrogen) and 10% FCS and incubated for 24 h at
37 °C/5% CO2. After incubation the effect of each antagonist or agonist was
analysed by X-gal staining.
To determine whether the manipulation of tissues during bead implants
caused surrounding cells to become necrotic, tissues were incubated in a 1:5000
dilution of Nile Blue (Sigma) for 15 min at 37 °C. Tissues were then washed
with PBS for 15 min at room temperature and photographed immediately under
bright field illumination.
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pΔAP2 transgenic embryos were recovered, stained using X-Gal and fixed
for 1 h in 4% paraformaldehyde PBS at 4 °C. After fixing, embryos were
equilibrated through a series of sucrose/PBS concentrations (5%, 10% and 25%)
at 4 °C and snap-frozen in OCT medium for cryosectioning. 10-μm sections
were cut and mounted on Polysine-coated slides (VWR) using a Hacker Bright
Clinicut cryostat. Sections were permeabilised in 100% methanol for 10 min at
−20 °C, washed in PBS 3×5 min and then pre-blocked for 1 h in TBST (pH 7.5;
25 mM Tris, 150 mM NaCl, 3 mM KCl and 0.1% TritonX-100) containing 3%
BSA and 4% goat serum at room temperature. After washing in PBS sections
were incubated with rabbit anti-human PAX3 (C-20) antibody (Santa Cruz
Biotechnology, Inc) in TBST/3% BSA/4% serum, in a humidified chamber,
overnight at 4 °C. Samples were then incubated with secondary antibody (Alexa
Fluor 488 donkey anti rabbit IgG, Molecular Probes) in TBST/3% BSA/4%
serum, in a dark humidified chamber, for 1 h at room temperature. Slides were
then mounted in VECTASHIELD® mounting medium with DAPI (Vector labs)
and visualised immediately with an Axioskop 2 plus microscope (Zeiss) with
HBO100 FluoArc mercury lamp and GFP filters. Images were analysed using
Axiovision Viewer 3.0 imaging software.Fig. 1. rVISTA plot comparing 9 kb surrounding the human locus transcriptional sta
chicken, opossum, rat, mouse and dog. The x-axis represents linear distance with ref
conservation between 50% and 100%. Exonic Msx1 sequence has been highlighte
sequence conserved for more that 75% over 100 base pairs in intergenic non-coding,
grey boxes represent areas of human repetitive sequence including LINEs, SINEs an
(DE) and proximal (PE) elements are highlighted using black boxes.Results
Sequences within both the DE and PE elements have been
highly conserved through evolution
In order to determinewhether the PE andDE elements that we
had previously described (MacKenzie et al., 1997) had been
conserved through evolution we undertook a comparative
genomic bioinformatics analysis. Using the ECR browser
flanking regions 5′ of the human Msx1 transcriptional start site
were compared to the genomes of 8 different vertebrate species
(Fig. 1). In a manner entirely consistent with their previously
demonstrated roles as tissue specific gene regulatory elements
(MacKenzie et al., 1997) it was shown that sequences within
both PE and DE had been highly conserved through evolution
(Fig. 1). DE has been conserved for 450 million years since the
divergence of tetrapods and fishes (Blair Hedges and Kumar,rt site (+1) compared to (from top to bottom) zebrafish, puffer fish (Fugu), frog,
erence to the human genome sequence. The y-axis represents levels of sequence
d as Exon 1 and Exon 2. Red, blue, pink and yellow peaks represent areas of
exonic, intronic and untranslated regions (3′ and 5′) respectively. Green bars and
d Alu sequences that were excluded from the analysis. The location of the distal
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of this enhancer and the Msx1 gene in correct facial develop-
ment. Although PE had been conserved since the divergence of
humans and amphibians (360 million years; Blair Hedges and
Kumar, 2003) it was not so well conserved in fish (Fig. 1).
PE contains a number of highly conserved putative
transcription factor binding sites
In an attempt to predict the identity of the transcription
factors responsible for supporting the tissue-specific activity of
the PE enhancer we undertook a TRANSFAC analysis of the PE
element in a number of different species. We were able to
predict that PE contained the highly conserved predicted
binding consensus sequences of three transcription factor (TF)
families that have members known to be highly expressed in the
developing limb bud mesenchyme such as AP-2, TCF and ETS
(see Fig. 2). All of these families of proteins have members
known to be expressed in the limb bud where PE has been
shown to be active (Ayadi et al., 2001; Cho and Dressler, 1998;
Moser et al., 1997). The best conserved of these predicted
consensus sequences were those of the TCF and ETS TF
families that have been perfectly conserved within the PEFig. 2. A multiple alignment of the human, chimp, dog, rat, mouse, opossum (Monod
(highlighted in red). Transcription factor binding sites as predicted by TRANSFAC
sequence above each of the lines of sequences. A key for each of the transcription
highlight the extent of the sequence removed to produce the pΔAP2 and pΔTES delet
purple letters. The SMAD binding site represented by a broken black box relates toelement since chicken–human divergence 310 million years ago
(Fig. 2) (Blair Hedges and Kumar, 2003). In addition it was
noted that the predicted TCF and ETS binding consensus sites
were immediately adjacent to a previously predicted SMAD
binding site ((Alvarez Martinez et al., 2002), see Fig. 2) that our
TRANSFAC analysis failed to detect at the high selection
stringencies used (core similarity=1, matrix similarity=0.9).
PE is made up of regulatory sub-domains able to support
nested gene expression domains within limb bud mesenchyme
Using pronuclear injection we produced several transient
transgenic embryos with pPEDE and analysed their expression
by β-gal expression at embryonic day 10.5 (E10.5, Figs. 3A, E
and 4C). The pPEDE construct was shown to produce strong
expression throughout the limb bud mesenchyme (Figs. 3A, E
and 4C) in a pattern identical to that previously described for the
p29NB construct that contained a 238 bp NheI/BglI fragment of
mouse DNA surrounding PE (construct 14; MacKenzie et al.,
1997).
In order to assess the role of the predicted AP2 binding
consensus in supporting the activity of the PE construct during
limb development, we used unique restriction sites within PE toom), chicken and frog proximal sequences demonstrating levels of conservation
(matrix similarity≥0.90, core similarity=1) highlighted as areas of coloured
factor binding sites is displayed in the bottom right-hand corner. Black arrows
ion constructs. Sequences altered by site-directed mutagenesis are highlighted by
that previously described in PE (Alvarez Martinez et al., 2002).
Table 1
Column 1, diagrammatic line drawings of the constructs used in this study (not to scale) showing the linear relationship of each plasmid
This diagram shows restriction sites in black vertical italic text. Inactivated restriction sites are highlighted with †. Putative transcription factor binding sites (AP2, TCF,
ETS and SMAD) are in upper case bold letters. Within pH7LacZ Msx1 (orange–red box) represents a fragment of the mouseMsx1 gene that contains the translational
start plus 44 amino acid codons from theN-terminus as previously described (MacKenzie et al., 1997). The sequences corresponding to PE andDE are represented by red
and green boxes respectively. The total size of the genomic fragment represented in pH7LacZ is 4.9 kb (refer toMacKenzie et al., 1997 for more details). hβg refers to the
human beta-globin promoter and pA represents a SV40 virus polyadenylation signal as previously described (Yee and Rigby, 1993). Sequence changes produced using
site-directedmutagenesis within the putative TCF4 binding site of pΔAP2 to produce pΔAPΔTCF have been highlighted using red letters. Column 2 displays the names
of each construct (see Methods section) and the third column shows the numbers of consistently staining embryos and transgenic founders combined for each construct.
(For interpretation of the references to colour in this table legend, the reader is referred to the web version of this article.)
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binding site to produce pΔAP2 (see Fig. 2 and Table 1).
Transgenic embryos produced using the pΔAP2 construct
produced staining patterns similar to the pPEDE previously
reported in the trunk and head region (see Fig. 3B). However,
the pΔAP2 transgene produced two localised and superficial
domains of expression in mesenchyme directly beneath the
ventral and dorsal aspects of the limb bud that constituted a
nested subset of the LacZ expressing mesenchyme produced by
the pPEDE construct (see Figs. 3F and 4D). These areas of
expression strongly resembled expression patterns previously
reported for the Pax3 gene in limb mesenchyme (Bendall et al.,
1999) and suggested that pΔAP2 transgene may be active
within limb bud muscle precursor cells.
In order to co-localise the expression of the pΔAP2
transgene with that of Msx1 we produced transgenic lines
using the pΔAP2 construct and carried out a combination of
LacZ staining (with salmon-gal) and whole mount in-situ
hybridisation using DIG labelled antisense Msx1 probes on
E10.5 embryos derived from these lines. Sectional analysis of
the limb buds of these transgenic embryos revealed a spatial
overlap in the expression of the pΔAP2 transgene and Msx1
consistent with the role of the PE element in supporting
expression of Msx1 in this area (Figs. 5A–C).In order to test the combined role of the TCF and ETS
predicted by TRANSFAC, in addition to the SMAD sites pre-
dicted by previous studies (Alvarez Martinez et al., 2002), we
produced a second deletion construct from the pPEDE plasmid,
called pΔTES, that removed all of these predicted consensi (see
Fig. 2 and Table 1). Transient transgenic embryos produced
using the pΔTES construct did not show any consistent staining
within the mesenchyme of the limb bud or the dermomyotome
component of the somites (Fig. 3C). Thus, the 21 base pairs of
sequence within the PE that contains highly conserved putative
TCF, ETS and SMAD binding sites are critical for supporting
the expression of LacZ produced by the pΔAP2 transgene
within the mesenchyme of the limb in a pattern consistent with
the known expression of Msx1 in limb bud muscle precursor
cells.
pΔAP2 supports gene expression in Pax3 expressing muscle
precursor cells
Previous studies have demonstrated the expression of Msx1
in cells of limb bud muscle precursor cells that also express
Pax3; an accepted marker of this cell population (Bendall et al.,
1999; Houzelstein et al., 1999). In order to test whether the
pattern of expression produced by the pΔAP2 transgene was
Fig. 4. (A and B) Localisation of (A) Msx1 and (B) TCF4 mRNA transcripts within vibratome sections of E10.5 limb buds analysed by whole-mount in situ
hybridisation. (C and D) Localisation of the expression of the βgal protein within vibratome sections of E10.5 embryo limb buds transgenic for the pPEDE (C) and
pΔAP2 constructs (D).
Fig. 3. (A–D) Transgenic E10.5 embryos produced by pronuclear injection of the pPEDE construct (A), the pΔAP2 construct (B) the pΔTES construct (C) and the
pΔAP2ΔTCF construct (D) demonstrating the tissue specific distribution of each construct in whole-mount. (E and F) Whole-mount micrographs demonstrating the
distribution of LacZ expression in the limb buds of E10.5 embryos transgenic for the pPEDE construct (E) and the pΔAP2 construct (F). (G) Whole-mount in situ
hybridisation in a E10.5 embryo limb bud using an antisense probe directed against transcripts of TCF4. dm, dermomyotome.
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Fig. 5. (A–C) Vibratome sections of E10.5 pΔAP2 transgenic limb buds stained for the expression of the LacZ gene using salmon-gal (pink/purple cells) and Msx1
mRNA using whole mount in situ hybridisation. (D) 10 μm section of pΔAP2 transgenic limb buds stained for the expression of LacZ using X-gal (blue cells) and (E)
for the presence of Pax3 by fluorescence immunohistochemistry. (F) False colour superimposition demonstrating the co-expression of LacZ (false colour red
highlighted with arrowheads) from the pΔAP2 transgene and the expression of the Pax3 myogenic marker (light green). (G–I) A high power micrograph (×400)
demonstrating co-expression of the pΔAP2 transgene (G) and Pax3 (H) at the cellular level. (I) False colour superimposition demonstrating the co-expression of LacZ
expression (false colour red) from the pΔAP2 transgene and the expression of the Pax3 myogenic marker (light green). Scale bar, 50 μm.
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precursor cells we carried out imunohistochemistry on cryo-
tome sections of X-gal stained E10.5 embryos derived from
established pΔAP2 transgenic lines using a Pax3 antibody. We
were able to demonstrate that the pΔAP2 construct could
support the expression of LacZ in a subset of cells of the limb
bud cells that corresponded to Pax3-expressing limb bud
muscle precursor cells (see Figs. 5D–I). This observation is
entirely consistent with the results of previous studies
demonstrating the co-expression of Msx1 in Pax3-expressing
limb bud muscle precursor cells (Houzelstein et al., 1999) and
shows that PE contains a nested regulatory subdomain that
contains a putative TCF/ETS binding site capable of supporting
the expression of Msx1 in limb bud muscle precursor cells.
The PE element does not contain a limb-specific BMP response
element
We have shown that a 21 base pair sub-domain of the PE
element that contains a highly conserved TCF/ETS binding
consensus, predicted by the TRANSFAC database, is respon-
sible for supporting limb bud pre-muscle mass activity. In
addition to the predicted TCF/ETS binding consensus, this 21
base pair region also contained a predicted conserved SMAD
binding domain that, although not highlighted by TRANSFAC,
was previously reported, together with two other predicted
SMAD sites, within 5 kb of 5′ sequence immediately flankingMsx1 (Alvarez Martinez et al., 2002). SMAD transcription
factors are part of the BMP signalling system that is known to
induce the expression ofMsx1 in limb bud mesenchyme (Ganan
et al., 1996, 1998; Ovchinnikov et al., 2006; Wang and Sassoon,
1995). It has been suggested that the presence of several
putative SMAD binding sites within 5 kb of the Msx1 start site
indicates the existence of one or more BMP responsive
elements (Alvarez Martinez et al., 2002). If this is indeed the
case then it is also possible that one of these predicted SMAD
binding sites may contribute to the limb bud muscle precursor
cell activity produced by the pΔAP2 construct.
In order to explore this possibility we first made transgenic
lines with the pH7LacZ plasmid (see Table 1) (MacKenzie et
al., 1997) that contained 5 kb of Msx1 5′ flanking DNA linked
to a LacZ marker gene that contained all the SMAD binding
sequences previously predicted (Alvarez Martinez et al., 2002)
and which also contained the PE element (MacKenzie et al.,
1997). Transgenic limb bud explants from these lines were
then isolated and cultured in the presence of beads soaked in
BMP4. In situ hybridisation demonstrated that the endogenous
Msx1 gene was able to respond to exogenously applied BMP4
(see Figs. 6A and B). However, we were unable to detect any
BMP response from the transgene (see Fig. 6C). These results
argue against the role of the previously predicted SMAD
binding site within the PE element in up-regulating the
expression of Msx1 in limb bud muscle precursor cells in
response to BMP.
Fig. 7. Chromatin immunoprecipitation (ChIP) assay to determine TCF4–PE
interaction in primary E10.5 mouse embryo cells. E10.5 mouse embryos were
dissociated into single cells and then incubated for 2 h in the presence or absence
of the Wnt signalling agonist BIO or the adenylate cyclase agonist forskolin
(For). Immunoprecipitation rates were quantified using agarose gel-based
densitometry (Panel A) and quantitative PCR (qPCR; Panel B). Panel A: Input,
PCR from chromatin preparation sample prior to ChIP assay. Mouse IgG, PCR
from ChIP assay carried out using non-specific mouse IgG. Anti-TCF4, PCR
from ChIP using anti-TCF4 antibody. Panel B: PCR analysis using densitometry
and SYBR Green quantification. Fold-enrichment calculated as fold-change of
anti-TCF4 ChIP compared to mouse IgG ChIP samples.
Fig. 6. (A and B) Localisation ofMsx1 transcripts by radioactive in situ hybridisation within sections of E 11 limb bud explants exposed to Affigel Blue beads soaked
in BMP4 for 24 h. (C) An E11 limb bud explant transgenic for the construct pH7LacZ (see Table 1) demonstrating a lack of responsiveness of the transgene to BMP4.
Solid white spot, insertion point of the Affigel Blue beads.
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required for activity of PE within limb bud pre-muscle
mass cells
A number of studies have demonstrated that the final
patterning of limb bud pre-muscle mass cells is dependent
on the Wnt signalling pathway whose effects are mediated
at the DNA level by the TCF family of transcription factor
proteins (Anakwe et al., 2003; Cossu and Borello, 1999;
Kardon et al., 2003). To test the contribution of the pre-
dicted TCF binding consensus on the ability of the PE
element to support limb mesenchyme cell-specific expression
we used the available TRANSFAC matrix to predict which
nucleotide changes within the TCF consensus would cause
most disruption to TCF binding. Key nucleotides within the
identified TCF consensus sequence of the pΔAP2 plasmid
were mutated to produce the construct pΔAP2ΔTCF (see
Fig. 2 and Table 1). We then carried out a transgenic
analysis of the pΔAP2ΔTCF construct. Transgenic embryos
produced using this construct demonstrated expression
patterns of LacZ that were almost identical to that
previously produced by the pΔTES construct in transgenic
animals in that they lacked any transgene expression in
either limb bud pre-muscle mass cells or within somatic
dermomyotome cells (Fig. 3D). These observations show
that the predicted TCF binding consensus within PE is
required to support the limb bud pre-muscle mass specific
expression of the PE enhancer.
TCF4 is co-expressed in an area of the limb bud that also
expresses the pΔAP2 transgene
To better understand the regulatory systems controlling
Msx1 expression in limb pre-muscle mass cells it is critical that
the specific identity of the protein–DNA interactions involved
are established. To better determine the possible relationship
between the TCF4 and limb bud pre-muscle mass activity of the
PE element we carried out whole mount in situ hybridisation on
wild type E10.5 mouse embryos using an antisense probe
against TCF4 mRNA. We were able to demonstrate that
expression of TCF4 transcripts colocalised to an area ofmesenchyme within the limb bud (see Figs. 3G, and 4B) that
coincided with the expression of the pΔAP2 transgene (see
Figs. 3F, and 4D).
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bind the PE element in vivo
To test the possibility that the TCF4 protein could interact
with PE we designed PCR primers against the endogenous PE
flanking the putative TCF binding site and carried out a ChIP
assay using an antibody specific for the TCF4 protein.
Normally ChIP assays are carried out on homogeneous and
transformed cell line populations. However, we were
concerned that using transformed cell lines would reduce
the relevance of the ChIP assay results to the embryonic
system we were attempting to examine, hence the use of
E10.5 single-cell suspensions for all ChIP assays. Further-
more, it has been widely recognised that binding of the TCF
transcription factors to target DNA is dependent on activation
of the Wnt signalling pathway. In order to further explore the
possible involvement of the Wnt signalling pathway in the
binding of TCF4 to PE we undertook a separate ChIP assay
in the presence of the potent Wnt signalling agonist BIO (see
Methods section). In the absence of BIO we were able to
detect a small but discernable interaction of the TCF4
transcription factor with PE within the disaggregated mouse
embryo cells (see Fig. 7). However, in the presence of BIO
the interaction of TCF4 with PE was significantly increased
(see Fig. 7). This significant increase was detected in two
separate experiments and quantified using both densitometry
and qPCR (see Fig. 7). These observations are consistent with
the hypothesis that disaggregated mouse embryo cells have a
reduced ability to communicate via the Wnt signallingFig. 8. (A–D) E10.5 pΔAP2 transgenic limb explant cultures demonstrating the effe
Left to right indicates the distal–proximal of each limb bud. (A) Limb bud exposed
transgene (LacZ) expression of bead soaked in panels PBS (B), DKK (C) and Wntpathway, thus reducing TCF4 binding. Only by artificially
stimulating the Wnt pathway using a specific Wnt agonist can
we increase TCF4 binding. In order to determine the
specificity of this up-regulation to the Wnt signalling pathway
we also incubated disaggregated mouse cells in the presence
of the adenylate cyclase agonist forskolin. Analysis of the
interaction of TCF4 with PE by ChIP analysis in these
forskolin treated cells suggests that TCF4 binding is
independent of cAMP/PKA-signalling and supports the
hypothesis that the Wnt signalling pathway may be specific
in supporting the limb bud muscle precursor cell expression
of Msx1. We next explored the possibility that Wnt-signalling
may functionally modulate the activity of PE in supporting
limb bud muscle precursor cell specific transcriptional
activity.
Activity of the pΔAP2 transgene in limb bud muscle precursor
cells is altered in the presence of Wnt signalling agonists and
antagonists
We have provided evidence that the PE element is unlikely
to contain any of the SMAD binding BMP response elements
known to control the expression of the Msx1 gene in limb bud
mesenchyme. TRANSFAC analysis of the PE element
predicted the possible presence of binding sites for AP2,
TCF and ETS transcription factor family members (Fig. 2).
The DNA binding properties of these transcription factors
have previously been shown to be stimulated following the
activation of a number of different signalling systems. Forcts of application of Wnt-signalling antagonist and agonist compounds for 24 h.
to Nile blue dye following incubation with a bead soaked in DKK. Effects on
agonist (D).
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members are known to be stimulated by the Wnt signalling
pathway (Kardon et al., 2003). We explored the hypothesis
that PE activity in migrating limb bud pre-muscle masses may
be dependent on one of these signalling systems. We
developed a transgenic explant culture assay using E10.5
pΔAP2 transgenic fore-limb bud explants. AG-1X2 formate
or Affigel blue beads containing various concentrations of
signal pathway agonists or antagonists were placed under the
epidermis of these transgenic explants, which were then
cultured for a further 24 h. Following culture these explants
were stained for the expression of the transgene with X-gal.
No consistent effect on the expression patterns of the pΔAP2
transgene were produced following culture with Affigel Blue
beads soaked in the BMP antagonist noggin (n=5, data not
shown). This observation was consistent with the results of
our studies (described above) showing a lack of any BMP
response elements within 5 kb of the Msx1 transcriptional
start site. Furthermore, we were also unable to observe any
consistent effects on transgene expression following applica-
tion of the FGF antagonist SU5402 (n=5; data not shown).
However, we were able to demonstrate that the Wnt signalling
pathway antagonist DKK was able to reduce LacZ expression
of the pΔAP2 transgene in cells immediately proximal to the
Affigel Blue beads soaked in this antagonist (n=3, see Fig.
8C). Interestingly, although the pattern was consistent, the
zone of LacZ non-expressing cells surrounding DKK soaked
beads were not symmetrical such that cells proximal of the
bead implant zone were more DKK-1 sensitive than those
distal to the bead implant site (see Fig. 8C). In order to rule
out the possibility that the lack of LacZ expression
surrounding the beads was a result of DKK-1-induced
necrosis or cell death we cultured explants overnight in the
presence of DKK-1-soaked beads and then stained them with
Nile blue as a marker for necrotic cells (Kimura et al., 2005).
Although we detected many necrotic cells at the periphery of
the explant we did not detect a large increase of dead cells
immediately surrounding the bead implant site (see Fig. 8A)
demonstrating that the effects of DKK-1 on transgene
expression were not a result of cell death. Furthermore, we
were able to demonstrate that ectopic expression of the
transgene could be induced in pΔAP2 transgenic limb buds
exposed to beads soaked in Wnt signalling agonist (see Fig.
8D). These results complement the observed Wnt signalling
pathway-stimulated interaction of the TCF4 transcription
factor with PE and further support the hypothesised role of
the Wnt/TCF signalling pathway in modulating the patterning
of limb muscle development (Anakwe et al., 2003; Cossu and
Borello, 1999; Kardon et al., 2003).
Discussion
Previous studies have demonstrated the expression of the
anti-myogenic factor Msx1 within muscle precursor cells of
the developing limb bud (Bendall et al., 1999; Houzelstein et
al., 1999). It has been hypothesised that the role of Msx1 in
these cells is to prevent their premature differentiation intomuscle cells, thus allowing them to migrate distally within the
growing limb bud behind the advancing progress zone
(Bendall et al., 1999; Houzelstein et al., 1999). In the present
study we have used a combination of predictive comparative
genomics, transgenic analysis, in situ hybridisation, and ChIP
assay to explore the regulatory systems responsible for
supporting the expression of the Msx1 gene in these muscle
precursor cells.
The rapid verification of our previous studies (MacKenzie et
al., 1997) using comparative genomics highlights the enormous
predictive power of using comparative genomics for locating
critical human enhancer sequences (MacKenzie et al., 2004;
Muller et al., 2002; Wasserman and Fickett, 1998). Moreover,
our studies further suggest that comparisons of the human
genome with that of the chicken genome appear to give the best
indication of the location of human enhancer sequences
(Davidson et al., 2006a,b).
In addition to verifying our earlier observations with regard
to identification of PE, comparative genomic analysis demon-
strated that the PE had not been highly conserved in fish
(Fig. 1). This observation suggests that PE induced expression
of Msx1 may not be required in the development of fins that,
in comparison to tetrapod limbs, lack distal limb musculature.
Therefore we would like to hypothesise that one of the
evolutionary driving forces during development of the first
weight bearing limbs by the early tetrapods was the evolution
of the PE element that drove the expression of Msx1 in
developing limb muscles.
Through the use of a combination of comparative genomics
and the prediction of transcription factor binding consensi
using TRANSFAC analysis we were able to predict the
putative binding sites of a number of different transcription
factors, including a highly conserved binding consensi for a
TCF transcription factor within the PE. To determine the
individual contribution of this predicted TCF binding site we
used a combination of site-directed mutagenesis and trans-
genic analysis to demonstrate the importance of this putative
TCF binding site to PE activity in limb bud muscle precursor
cells. We were also able to demonstrate that TCF4 is
expressed in limb bud muscle precursor cells and provided
evidence for a direct Wnt-signalling inducible interaction
between the TCF4 transcription factor and the PE element
using ChIP analysis in dissociated E10.5 primary embryonic
cells. Previous studies have reported that TCF4 is expressed
in lateral plate derived mesoderm but not in somite derived
muscle precursor cells (Kardon et al., 2003). Based on these
studies it was proposed that these TCF4 expressing lateral
plate mesoderm cells were critical to muscle patterning. Here
we provide evidence that TCF4 is involved in the up
regulation the expression of Msx1 in Pax3 expressing limb
bud cells through the PE. These different results can be
reconciled if we consider that TCF4 and Msx1 in these Pax3
expressing cells might form part of a negative feedback
mechanism that ensures low levels of TCF4 expression in
muscle precursor cells. Moreover, considering its known role
in repressing muscle specific gene expression, the expression
of Msx1 in TCF4 expressing cells in the limb bud may also
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muscle specific genes.
Consistent with previous observations (Bienz, 2005) we
present evidence that binding of TCF4 to the PE element can be
induced by stimulation of the Wnt signalling pathway. In
addition to verifying the Wnt stimulated binding of TCF4 to PE
we were also able to modulate the expression of the pΔAP2
transgene in limb bud muscle precursor cells with Wnt
signalling agonists and antagonists. These data support the
hypothesis for a role for the Wnt/β-catenin/TCF pathway in
modulating muscle development through regulation of the anti-
myogenic Msx1 gene. The role of the Wnts in patterning limb
muscle tissue has previously been highlighted (Anakwe et al.,
2003). Three Wnt proteins are known to be expressed within the
developing limb bud mesenchyme; Wnt5a, Wnt11 and Wnt9a
(Anakwe et al., 2003). Of these, only Wnt11 is expressed in a
pattern that correlates with the distribution of myogenic
precursors in the limb bud (Anakwe et al., 2003). Closer
inspection of the expression ofWnt11 in the limb buds reveals a
thin zone of Wnt11-expressing cells that overlies limb bud
muscle precursor cells (Anakwe et al., 2003). We therefore
hypothesise that Wnt11 may be part of the regulatory system
that controls the expression of Msx1 in these cells (see Fig. 9).
As previously mentioned, a number of different studies have
demonstrated the expression of the muscle de-differentiation
gene,Msx1, within cells of the developing musculature (Bendall
et al., 1999; Houzelstein et al., 1999; Odelberg et al., 2000;
Thompson-Jaeger and Raghow, 2000; Woloshin et al., 1995).Fig. 9. A hypothetical regulatory system based on previous findings (Anakwe
et al., 2003) and the findings of the current study demonstrating the relationships
between the canonical Wnt/TCF4 pathway and the Msx1/Pax3/MyoD pathway
via theMsx1 proximal enhancer. Mode 1 refers to the direct interaction of Msx1
with the MyoD core enhancer region (CER). Mode 2 refers to the repression of
MyoD expression by the direct protein–protein interaction of the Msx1 protein
with themyogenic transcription factor protein Pax3 thus preventing its binding to
theMyoD CER. β-cat refers to the β-catenin protein that is a critical component
of the WNT signalling pathway. Frz refers to the Frizzled receptor protein that
functions together with it co-receptor LRP.However, further study of the role of the Msx1 gene in
developing muscle cells is hampered by the fact that little
evidence of changes in muscle morphology has been reported in
either Msx1−/− or Msx1−/−/Msx2−/− animals. Therefore, it may
be possible that the roles of the Msx1 gene within developing
limb muscle are redundant with a gene other than Msx2.
Another possibility with respect to the limited effects of
Msx1−/− or Msx1−/−/Msx2−/− on limb muscle development may
be related to the particular way that the Msx1 gene was targeted
in both published models (Houzelstein et al., 1997; Satokata
and Maas, 1994). In keeping with its known role as a
transcriptional repressor Msx1 has been shown to bind and
repress the activity of the core enhancer region (CER), of the
MyoD gene that is essential for initial activation and restricted
expression of MyoD during embryogenesis (Lee et al., 2004).
The ability of Msx1 to bind DNA and influence transcription
relies on the integrity of its homeodomain with the third helix
being the most critical to DNA binding and recognition.
Indeed, both of the reported Msx1 gene deletion mouse
models produced removed the 3rd helix from the Msx1 gene
and all sequence 3′ (Houzelstein et al., 1997; Satokata and
Maas, 1994) leaving the majority of the protein coding
sequence 5′ of this deletion site intact and possibly able to
produce active protein. More recent evidence now suggests
that direct protein–protein interaction with other transcription
factor proteins of the Pax, Dlx and Lhx families may be a
second mode of action through which the Msx1 protein may
exert its repressive influence on transcription and thus limb
muscle development (Bendall et al., 1998, 1999; Bryan and
Morasso, 2000; Zhang et al., 1997). These studies show that
the Msx1 protein interacts with the Pax and Dlx proteins via
the N-terminal and the first helix domain of its homeodomain.
Both the N-terminal domain and the first helix of the Msx1
homedomain remain intact in both of the Msx1 gene deletion
models reported (Bendall et al., 1998, 1999; Bryan and
Morasso, 2000; Zhang et al., 1997). Therefore, it is possible
that the truncated Msx1 protein produced in both of these
knockout models may only have disrupted the ability of the
protein to bind DNA whilst retaining sufficient protein
binding activity to allow the normal development of a
number of different organ systems. To address the possibility
that the products of Msx1 in both reported Msx1−/− models
still retain residual activity a complete null model, that would
inactivate the entire Msx1 gene-coding sequence, is required.
Conclusions
Misregulation of muscle-specific gene expression and the
dedifferentiation of muscle cells to transcriptional profiles more
reflective of embryonic cells has been shown to be character-
istics of many forms of muscular degenerative diseases (Chen et
al., 2000; Tupler et al., 1999). It is therefore possible that the
progression of these diseases may be exacerbated by the mis-
expression of muscle dedifferentiation factors such as Msx1.
Gaining a better understanding of the regulatory systems
underlying normal muscle differentiation, and whereMsx1 may
fit into these systems, may provide insights into the progression
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reverse their devastating effects.
Understanding the regulatory systems that control the
expression of genes during limb muscle patterning and
differentiation is critical to understanding the development of
the limb musculature. Prior to the availability of multiple
vertebrate genome sequence understanding the regulatory
systems that control the expression of critical genes was
difficult due to the inability to rapidly identify and characterise
the relevant enhancer sequences that serve pivotal roles within
these systems. The current study demonstrates that comparative
computer analysis of the newly available genome sequences of
many different genomes is a powerful tool in facilitating the
analysis of gene regulatory systems. We have used comparative
genomics to predict a functional linkage between two regulatory
systems that had not previously been correlated within
developing limb muscle, that of the canonical Wnt/TCF
signalling pathway and that of the Pax3/MyoD cellular
differentiation pathway. Although there is now little doubt
that predictive genomics is extremely powerful the major
challenge for the future will undoubtedly involve the further
development of techniques that can validate these predictions,
hence preventing the development of a “bioinformatics
validation gap”.
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